| Reduced Risk Status: |
|
| IPM Compatibility: |
PER REQUESTOR 2016 NOMINATION COMMENT: VERY GOOD IPM FIT; IS NOT LISTED AS HAVING ANY EFFECT ON BOMBIDS, ENCARSIA, AND ERETMOCERUS SPP.:09/16
|
| Reasons for need: |
BACTERIAL CANKER (CMM)
|
| Requesting State(s): |
AZ:Tifft, K. ; CA:Stefcu, D. ; FL:Bledsoe, M. ; ME:Roderick, E. ; NC:Quesada, L. ; UT:Stefcu, D, ;
|
| PCR Use Pattern: |
6-8 OZ/A; FOLIAR
|
| EPA Default Residue Trials: |
ANY 4 TRIALS
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
TANOS IS LABELED FOR BACTERIAL CANKER SUPPRESSION (EXCEPT IN CA) ON FIELD TOMATOES AND SILENT ON GH USE, BUT FOR COMMERCIAL GH PRODUCTION USE IT SHOULD BE OK; CANADA PRIORITY FOR FAMOXADONE/COPPER WAS WITHDRAWN: 06/14; FAMOXADONE IS AN EPA CAUTION:08/16; MFG INDICATES NO ADITIONAL RESIDUE DATA ARE NEEDED IN THE US (THERE IS GH DATA FROM THE EU):09/16
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|